Key Quantitative Figures

  • Investment amount: ₹3,150 crore in primary capital
  • Stake acquired: 24.9% significant minority stake
  • Current bed capacity: ~2,800 beds across 9 multi-speciality hospitals
  • Announced capacity: ~3,250 beds
  • Advent International's assets under management: Over USD $109 billion as of June 30, 2026

Parties Involved

  • Yatharth Hospital and Trauma Care Services Ltd (NSE: YATHARTH, BSE: 543950)
  • Advent International (global private equity investor)
  • Tyagi Family (promoters)
  • Mr. Yatharth Tyagi, Whole-time Director
  • Pankaj Patwari, Managing Director at Advent
  • Atin Jain, Director at Advent
  • Ritesh Mishra, Company Secretary & Compliance Officer

Transaction Details

  • Definitive agreement signed for primary capital infusion
  • One of the largest primary infusions by a private equity firm in India's hospital sector
  • Promoter Tyagi Family will remain the largest shareholder post-transaction
  • Advent will hold significant minority stake of 24.9%

Company Background

Yatharth Hospitals operates nine multi-speciality hospitals across North India with presence in Noida, Greater Noida, Noida Extension, Greater Faridabad, New Delhi, Faridabad, Gurugram (NCR), Jhansi-Orchha (Madhya Pradesh), and Agra. Founded in 2008, the company has expanded through organic and inorganic growth.

Management Commentary

Mr. Yatharth Tyagi stated that Advent's investment validates the platform's strength and brings healthcare expertise, global insights, and value-creation mindset to accelerate next phase of growth.

Pankaj Patwari noted this investment reflects Advent's commitment to India's healthcare sector which is entering a decade of structural growth.

Atin Jain described Yatharth Hospitals as having a differentiated healthcare platform with clinical depth and disciplined execution.

Advent International Profile

  • Global private equity investor with 17 offices across five continents
  • $109 billion AUM as of June 30, 2026
  • 460 investments across 45 countries
  • Extensive healthcare experience: 55+ healthcare investments across 17 countries over 35+ years
  • Recent Indian healthcare investments: Apollo 24/7, Cohance, Felix Pharma, Bharat Serums and Vaccines, and Care Hospitals

Financial Impact

The ₹3,150 crore primary capital infusion represents a significant strengthening of the company's capital base. Specific financial impact on balance sheet or operational metrics not quantified in the disclosure.

Capital Structure Impact

Post-transaction capital structure will show Advent holding 24.9% stake with promoters remaining the largest shareholders. No dilution details or pre/post share capital figures provided.

#Tags: #YatharthHospitals #AdventInternational #PrivateEquity #HealthcareInvestment #SEBIDisclosure